soul trial oral semaglutide cardiovascular outcomes 2024 nejm Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM soul trial oral semaglutide cardiovascular

Clear understanding and ongoing monitoring remain essential as more long-term evidence continues to emerge

Growth hormone secretagogues: Selective stimulation and metabolic outcomes

This quality assurance removes another variable that could otherwise explain perceived effectiveness changes

Navarro has completed fellowships in Advanced Bariatric Surgery, Laparoscopic Surgery, and Advanced Trauma Life Support, all of which are necessary tools for dealing with current epidemics such as obesity and metabolic illnesses

Patients should discuss appropriate exercise levels with their healthcare provider, particularly if they have cardiovascular conditions or mobility limitations

The first serum I ever used in my life and its THE best serum ever